English
TitleProtective Effect of N-methyl-1-deoxynojirimycin on Lung Ischemia Reperfusion Injury: An in vivo Study | MdNM Reduces Lung Ischemia Reperfusion Injury |
SubtitleOriginal article
AuthorsKazuhiro Ito, Yasuyuki Shimada, Daishiro Kato, Junichi Shimada, Shogo Toda, Nobuo Kitamura
Authors(kana)
OrganizationDepartment of Cardiovascular and Thoracic Surgery, Kyoto Prefectural University of Medicine
JournalCirculation Control
Volume24
Number2
Page135-137
Year/Month2003/
ArticleOriginal article
PublisherJapan Society of Circulation Control
AbstractPurpose: The warm ischemic period following cardiac arrest damages the lungs. N-Methyl-1-deoxynojirimycin (MdNM) can preserve glycogen and reduce myocardial infarct size in rabbit heart. We tested the hypothesis that MdNM may reduce ischemia reperfusion injury of the lung using an in vivo rat model. Methods: We administered MdNM (30mg/kg) or saline intravenously. We clamped the left lung hilus for 60 minutes and then reperfused it for 60 minutes. We measured baseline arterial oxygen tension and calculated the percent recovery of the oxygen tension every 10 minutes during reperfusion. Results: The percent recovery of oxygen tension was significantly higher (p < 0.05) in the MdNM group (n = 6) than in the control group (n = 6) at the end of the 60 minutes of ischemia and during the initial 30 minutes of reperfusion. The oxygen tension was still higher in the MdNM group at the end of the 60-minute reperfusion, but the difference was not significant. Conclusion: Preischemic treatment with MdNM had a partial but significant protective effect against ischemia reperfusion injury of the lung.
PracticeBasic medicine
KeywordsLung ischemia reperfusion injury, Lung transplantation, Preconditioning, N-methyl-1-deoxynojirimycin

y‘S•¶PDFz